Figure 3.
Basal level of hMLH methylation in plasma DNA from ovarian cancer patients before treatment with azacitidine and carboplatin. A: Methylation PSR; B and C: Semi-quantitative measurement of normalized methylated hMLH.
Basal level of hMLH methylation in plasma DNA from ovarian cancer patients before treatment with azacitidine and carboplatin. A: Methylation PSR; B and C: Semi-quantitative measurement of normalized methylated hMLH.